InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
5
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-7.4%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Aronson Martha Goldberg, Director. Officer active across 3 companies, notably Cardiovascular Systems Inc. Cumulatively, 13 disclosures have been recorded. Breakdown: 5 buys · 0 sell. Total volume traded: €298k. History available since 10 May 2021. The latest transaction was disclosed on 3 October 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations13 total
19,594 shares0Common Stock, No Par ValueSEC:0001429832-25-000006:0
302 shares0Common StockSEC:0001127602-24-017848:0
2,000 shares@ US$70.98100.0% of flowCommon StockSEC:0001127602-24-014593:0
Ideal exit: 31 Jan 2025 (T+270)
335 shares0Common StockSEC:0001127602-23-017606:0
12,411 shares@ US$20.0057.6% of flowCommon StockSEC:0001062993-23-009604:0
2,411 sharesCommon StockSEC:0001437749-22-020820:0
812 shares0Common StockSEC:0001127602-22-016531:0
2,500 shares@ US$18.4324.2% of flowCommon StockSEC:0001437749-22-002892:0
Ideal exit: 4 Nov 2022 (T+270)
2,500 shares@ US$18.4348.5% of flowCommon StockSEC:0001437749-22-002892
Ideal exit: 4 Nov 2022 (T+270)
1,521 shares0Common StockSEC:0001127602-21-018892:0
1,521 shares0Common StockSEC:0001127602-21-018892
1,500 shares@ US$34.5925.8% of flowCommon StockSEC:0000914190-21-000144
Ideal exit: 4 Feb 2022 (T+270)
1,500 shares@ US$34.5925.8% of flowCommon StockSEC:0000914190-21-000144:0
Ideal exit: 4 Feb 2022 (T+270)
13 of 13 declarations
About Aronson Martha Goldberg
Martha Goldberg Aronson is a Director at Cardiovascular Systems Inc and CONMED Corp. She provides her expertise to the board, contributing to the strategy and governance of the companies. Her experience is valuable in guiding decisions and ensuring sustainable growth.
